Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Supreme Court Jumps Into Biosimilars Battle Over Launch Notification, Patent Dance

14 Jan 2017

• By Brenda Sandburg

US-Supreme-Court_V1_1200

Related Content

Biosimilar Sponsors Can Avoid Patent Dance, But Innovators Win Extra Exclusivity

22 Jul 2015

Biosimilar Launch Notification: Solicitor General Backs Pre-FDA Approval Notice

09 Dec 2016

Biosimilar Launch Notification May Head Back To Court

11 Sep 2016

Related Companies

Amgen, Inc.

Novartis AG

Johnson & Johnson

Celltrion, Inc.

Pfizer Inc.

Novartis AG

Apotex Inc.

Additional Topics

United States Biosimilars Legal Issues Policy BioPharmaceutical

More from Biosimilars

More from Biosimilars & Generics

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.